stockrowLiquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
Follow LQDA
Alert me
Liquidia Corporation (LQDA) EV/FCF
As of 5 November 2026, Liquidia Corporation (LQDA) trades at a EV/FCF of 25.6×. Over the past ten years it has ranged from −100× (February 2026) to 166× (June 2026); the current reading is higher than 94% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | −74.2× | — |
| FY2024 | −8.8× | — |
| FY2023 | −16.6× | — |
| FY2022 | −10.2× | — |
| FY2022 | −6.1× | — |
| FY2021 | −5.7× | — |
| FY2021 | −1.0× | — |
| FY2020 | −0.9× | — |
| FY2020 | −0.8× | — |
| FY2019 | −0.8× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 46.3× | (41.84%) |
| Mar 2026 | 79.6× | — |
| Dec 2025 | −74.2× | — |
| Sep 2025 | −19.2× | — |
| 25 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | −158× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −21.7× |
| RGC Regencell Bioscience Holdings Limited compare | 0.9× |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 7.5× |
| LNTH Lantheus Holdings, Inc. compare | 16.6× |
| PBH Prestige Consumer Healthcare Inc. compare | 19.2× |
| LQDA Liquidia Corporation | 25.6× |
| HIMS Hims & Hers Health, Inc. compare | 73.6× |
| SUPN Indivior Pharmaceuticals Inc. compare | 138× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on LQDA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement